Skip to content

Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe

Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04206241
Enrollment
278833
Registered
2019-12-20
Start date
2018-01-01
Completion date
2019-12-31
Last updated
2021-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS, HIV Infections, Infant Morbidity, Perinatal HIV Infection

Keywords

HIV, POC, EID

Brief summary

This study aims to assess the feasibility and, acceptability and effects of implementing HIV testing at birth testing using point-of-care (POC) HIV nucleic acid testing (NAT) in maternity settings.

Detailed description

This Unitaid-funded study aims to assess the feasibility and, acceptability and effects of implementing HIV testing at birth testing using point-of-care (POC) HIV nucleic acid testing (NAT) in maternity settings. Outcomes measures will include age at uptake of testing, turnaround time from testing to caregiver result receipt, HIV positivity rate, and timing of ART initiation for HIV-positive infants. This study will compare outcomes between HIV-exposed at high vs low risk of maternal HIV transmission. The study will also assess the impact of POC birth testing on retention in care and impact on subsequent testing at 6 weeks.

Interventions

DIAGNOSTIC_TESTPoint of care early infant diagnosis (POC EID)

HIV testing where the blood sample is processed at either the facility itself or a nearby site that is closer to the facility than a laboratory. With POC EID, blood samples do not have to travel to the laboratory for processing.

Sponsors

UNITAID
CollaboratorOTHER
Elizabeth Glaser Pediatric AIDS Foundation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 48 Hours
Healthy volunteers
Yes

Inclusion criteria

HIV-exposed infants (HEI) * All HEI who access maternity/post-natal services within 48 hours of life * Tested for HIV at birth using the POC NAT platform * Caregiver provides informed consent for participation Caregivers * Mother/caregiver of an HEI who was offered POC EID at birth * Able to provide informed consent to participate in the study Health workers * All health workers working in maternity services in the study sites * Provides informed consent to be interviewed Key informants (laboratory managers and program leads/focal persons) * Health managers working in the field of pediatric HIV services or PMTCT * Provides informed consent to be interviewed

Exclusion criteria

HIV-exposed infants (HEI) * HEI tested for HIV using conventional EID at project sites * HEI whose caregivers refuse birth testing * HEI where the clinician deems there is a contra-indication for sample collection for birth testing (e.g. severe hemophilia) Caregivers * Caregivers of HEI who cannot legally provide consent to participate in the study Health workers * Healthcare workers who do not make use of EID or results of EID Key informants * Key informants who cannot legally provide consent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Proportion of eligible HEI who present to pilot facilities who receive POC EID testing at birth18 monthsNumber of eligible HEI who received POC EID divided by the total number of eligible HEI

Secondary

MeasureTime frameDescription
Average number of days between sample collection of HEI and results received by caregiver18 monthsDate HEI sample collected minus date results received
Proportion of HEI tested at birth who are HIV positive18 monthsNumber of HEI tested at birth who are HIV positive divided by the number of HEI tested at birth
Proportion of HIV-infected infants tested at birth who are started on ART within 2 weeks of the birth test18 monthsNumber of HIV-infected infants tested at birth who are started on ART within 2 weeks of the birth test, divided by the number of HIV-infected infants tested at birth
Average number of days between sample collection of HEI and initiation on ART for infants testing HIV-positive18 monthsDate of sample collection of HEI minus date of date of ART initiation on ART for infants testing HIV-positive
Proportion of infants testing HIV negative at birth and who return for testing at 6-8 weeks18 monthsNumber of infants testing HIV-negative at birth who return for testing at 6-8 weeks, divided by the number of infants who tested HIV-negative at birth
Proportion of tested HEI whose caregivers receive results of the POC EID birth testing18 monthsNumber of HEI whose caregivers received results of the POC EID birth testing, divided by the number of HEI who received POC EID birth testing
The retention in care of positively-identified infants on birth testing for the first 3 and/or 6 months of life18 monthsNumber of infants who tested HIV-positive at birth in care at 3 and/or 6 months of life, divided by the number who tested HIV-positive at birth
Proportion of HEI tested at birth who meet criteria for high risk of vertical transmission18 monthsNumber of HEI tested at birth who meet the criteria for high risk of vertical transmission divided by the number who meet the criteria for high risk of vertical transmission
Proportion of high-risk infants according to the risk screening tool who test HIV-positive at birth18 monthsNumber of high-risk infants according to the risk screening tool who test HIV-positive at birth, divided by the number of high-risk infants according to the risk screening tool
Proportion of low-risk infants according to the risk screening tool who test HIV-positive at birth18 monthsNumber of low-risk infants according to the risk screening tool who test HIV-positive at birth, divided by the number of low-risk infants according the risk screening tool
Proportion of infants who test HIV-positive at 6-8 weeks of those who test negative at birth18 monthsNumber of infants who test HIV-positive at 6-8 weeks divided by those who tested HIV-negative at birth

Countries

Zimbabwe

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026